Inventor
WILLIAMS WILLIAM V
US24 patents
⚠️ This page may combine multiple inventors who share the name “WILLIAMS WILLIAM V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PENNSYLVANIA
15 patentsUS5981505ANov 9, 1999
Compositions and methods for delivery of genetic material
UNIV PENNSYLVANIA197 citations99
US5830876ANov 3, 1998
Genetic immunization
UNIV PENNSYLVANIA207 citations99
US5817637AOct 6, 1998
Genetic immunization
UNIV PENNSYLVANIA381 citations99
US5637677AJun 10, 1997
Biologically active compounds and methods of constructing and using the same
UNIV PENNSYLVANIA138 citations98
US6468982B1Oct 22, 2002
Genetic immunization
UNIV PENNSYLVANIA38 citations96
US5574009ANov 12, 1996
Method of stimulating myelination of cells
UNIV PENNSYLVANIA43 citations96
US5556744ASep 17, 1996
Methods and compositions for diagnosing and treating certain HIV infected patients
UNIV PENNSYLVANIA86 citations95
US5840300ANov 24, 1998
Methods and compositions comprising single chain recombinant antibodies
UNIV PENNSYLVANIA46 citations93
US5837460ANov 17, 1998
Methods of identifying biologically active receptor-binding peptides
UNIV PENNSYLVANIA77 citations93
US5219837AJun 15, 1993
Method of stimulating myelination of cells
UNIV PENNSYLVANIA28 citations92
US6248565B1Jun 19, 2001
Immunization with plasmid encoding immunogenic proteins and intracellular targeting sequences
UNIV PENNSYLVANIA21 citations90
US6228621B1May 8, 2001
Plasmids encoding immunogenic proteins and intracellular targeting sequences
UNIV PENNSYLVANIA25 citations90
US6087486AJul 11, 2000
Nucleotide sequences encoding vpr receptor protein
UNIV PENNSYLVANIA31 citations89
US5338829AAug 16, 1994
Peptides derived from human immunodeficiency virus-1 GP160
UNIV PENNSYLVANIA9 citations74
US6372884B1Apr 16, 2002
Biologically active compounds and methods of constructing and using the same
UNIV PENNSYLVANIA1 citations52
INCYTE CORP
6 patentsUS10166191B2Jan 1, 2019
Sustained-release dosage forms of ruxolitinib
INCYTE CORP32 citations97
US11337927B2May 24, 2022
Sustained-release dosage forms of ruxolitinib
INCYTE CORP12 citations93
US10874616B2Dec 29, 2020
Sustained-release dosage forms of ruxolitinib
INCYTE CORP17 citations93
US11896717B2Feb 13, 2024
Sustained-release dosage forms of ruxolitinib
INCYTE CORP0 citations62
US11576865B2Feb 14, 2023
Sustained-release dosage forms of ruxolitinib
INCYTE CORP0 citations62
US11576864B2Feb 14, 2023
Sustained-release dosage forms of ruxolitinib
INCYTE CORP0 citations62